Developmental potential of immature human oocytes aspirated after controlled ovarian stimulation

• Published in: Journal of assisted reproduction and genetics Vol. 38; no. 9; pp. 2291 - 2299
• Main Authors: Mandelbaum, Rachel S., Awadalla, Michael S., Smith, Meghan B., Violette, Caroline J., Klooster, Brittany L., Danis, Rachel B., McGinnis, Lynda K., Ho, Jacqueline R., Bendikson, Kristin A., Paulson, Richard J., Ahmady, Ali
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.09.2021; Springer Nature B.V
• Subjects: Adult; Assisted Reproduction Technologies; Embryo Transfer; Embryonic Development; Embryos; Female; Fertilization; Fertilization in Vitro - methods; Gynecology; Human Genetics; Humans; In Vitro Oocyte Maturation Techniques - methods; Maturation; Medicine; Medicine & Public Health; Metaphase; Oocytes; Oocytes - cytology; Oogenesis; Ovulation Induction - methods; Reproductive Medicine; Retrospective Studies; Sperm Injections, Intracytoplasmic - methods; Immature oocytes; Controlled ovarian stimulation; Intracytoplasmic sperm injection; In vitro maturation
• ISSN: 1058-0468; 1573-7330
• DOI: 10.1007/s10815-021-02253-7

Purpose Intracytoplasmic sperm injection (ICSI) for initially immature oocytes that mature in vitro is controversial and practice varies widely. While it may increase the number of usable embryos, it may also be time-intensive and potentially low-yield. This study sought to elucidate which patients may benefit from ICSI of initially immature oocytes that matured in vitro. Methods A retrospective study comparing fertilization, cleavage, blastulation, and embryo usage rates between sibling initially immature and mature oocytes that underwent ICSI between 2015 and 2019 was performed. Outcomes of initially immature oocytes were stratified by initial maturation stage, timing of progression to metaphase II (MII) in vitro, percentage of mature oocytes in the cycle, and female age. Results Ten thousand eight hundred seventeen oocytes from 889 cycles were included. Of 3137 (29.0%) initially immature oocytes, 418 (13.3%) reached MII later on the day of retrieval (day 0) and 1493 (47.6%) on day 1. Overall, embryos originating from initially immature oocytes had lower cleavage and blastulation rates compared to those from initially mature oocytes (P<0.05, all groups). However, embryos from oocytes that matured later on day 0 comprised a unique subset that had clinically similar cleavage (75% vs 80%, RR 0.93, P=0.047) and blastulation rates (41% vs 50%, RR 0.81, P=0.024) compared to initially mature oocytes. Women with low percentages of mature oocytes in the cycle overall and women ≥40 in cleavage cycles derived the highest relative benefit from the use of immature oocytes. Conclusion ICSI of immature oocytes, particularly those that mature later on the day of retrieval, may improve numbers of usable embryos. This study supports routine reassessment of immature oocytes for progression to MII and ICSI on day 0. An additional reassessment on day 1 may also be of use in older women or those with low percentage of mature oocytes.